Status:

RECRUITING

Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility

Lead Sponsor:

Hamad Medical Corporation

Collaborating Sponsors:

Qatar National Research Fund

Baylor College of Medicine

Conditions:

Diabetes Mellitus

Hemodialysis Complication

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

A high prevalence of diabetes has been reported in Qatar with nearly 23% population suffering from the pandemic, thereby increasing the associated healthcare cost. Low compliance with exercise and phy...

Detailed Description

This interdisciplinary project (Technology Readiness Level 9, TRL 9) aims to translate and clinically validate the effectiveness of an innovative wearable electrical stimulator technology for improvin...

Eligibility Criteria

Inclusion

  • Male and female patients with diabetes receiving dialysis who are \>40 years old.
  • Ambulatory (able to independently walk 20m with or without walking assistance).
  • Willing and able to provide informed consent.
  • Diabetes will be defined based on the American Diabetes Association (ADA) criteria (83).
  • Evidence of peripheral neuropathy and its severity will be determined based on a neurologic examination using criteria explained in the ADA statement.

Exclusion

  • Have an active foot ulcer, an active infection, Charcot neuroarthropathy, or major foot amputation.
  • Patients with any clinically significant medical or psychiatric condition, or laboratory abnormality that would, in the judgment of the investigators, interfere with the ability to participate in the study.
  • Patients concurrently participating in exercise training; major hearing/visual impairment; any patient with changes in psychotropic or sleep medications in the last 6 weeks.
  • If they were unlikely to fully comply with the follow-up protocol (e.g., travel plans).

Key Trial Info

Start Date :

June 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 11 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05407207

Start Date

June 1 2018

End Date

November 11 2022

Last Update

June 7 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Baylor College of Medicine, USA

Houston, Texas, United States, 77030

2

Hamad Medical Corporation

Doha, Qatar, 3050